Eiji Kumazawa

A New Water‐soluble Camptothecin Derivative, DX‐8951f, Exhibits Potent Antitumor Activity against Human Tumors <i>in vitro</i> and <i>in vivo</i>

Ikuo Mitsui, Eiji Kumazawa, Yasuhide Hirota et al. · Japanese Journal of Cancer Research · 1995 · 160 citations · Full text

Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice

Eiji Kumazawa, Takeshi Jimbo, Yusuke Ochi et al. · Cancer Chemotherapy and Pharmacology · 1998 · 79 citations

Tumor Biology, Drug Targeting, Oncology +9

Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea

Kiyoshi Takasuna, Toshihiko Hagiwara, Kyohei Watanabe et al. · Cancer Chemotherapy and Pharmacology · 2006 · 77 citations

Health Sciences, Gastrointestinal Oncology, Optimal Antidiarrhea Treatment +7

Antitumor Effect of DX‐8951, a Novel Camptothecin Analog, on Human Pancreatic Tumor Cells and Their CPT‐11‐resistant Variants Cultured <i>in vitro</i> and Xenografted into Nude Mice

Soichi Takiguchi, Eiji Kumazawa, Takao Shimazoe et al. · Japanese Journal of Cancer Research · 1997 · 39 citations · Full text

Synthesis and Antitumor Activity of Novel Pyrimidinyl Pyrazole Derivatives. II. Optimization of the Phenylpiperazine Moiety of 1-[5-Methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3-phenylpiperazinyl-1-trans-propenes.

Hiroyuki Naito, Satoru Ohsuki, Masamichi Sugimori et al. · Chemical and Pharmaceutical Bulletin · 2002 · 37 citations · Full text

Antitumor Activity, Organic Chemistry, Pharmacotherapy +16